Itch-specific neurons have been sought for decades. The existence of such neurons has been doubted recently as a result of the observation that itch-mediating neurons also respond to painful stimuli. We genetically labeled and manipulated MrgprA3 + neurons in the dorsal root ganglion (DRG) and found that they exclusively innervated the epidermis of the skin and responded to multiple pruritogens. Ablation of MrgprA3 + neurons led to substantial reductions in scratching evoked by multiple pruritogens and occurring spontaneously under chronic itch conditions, whereas pain sensitivity remained intact. Notably, mice in which TRPV1 was exclusively expressed in MrgprA3 + neurons exhibited itch, but not pain, behavior in response to capsaicin. Although MrgprA3 + neurons were sensitive to noxious heat, activation of TRPV1 in these neurons by noxious heat did not alter pain behavior. These data suggest that MrgprA3 defines a specific subpopulation of DRG neurons mediating itch. Our study opens new avenues for studying itch and developing anti-pruritic therapies.
a r t I C l e S Pain and itch are two basic modalities that are initiated and mediated by primary sensory neurons with cell bodies in the DRG or trigeminal ganglia. These neurons are highly diverse on the basis of their somal sizes, expression of ion channels and receptors, innervation territories, and electrophysiological properties 1 . Small-diameter DRG neurons with unmyelinated axons (C fibers) are major neuronal types for mediating pain and itch 1, 2 . The sensations of pain and itch are distinct, and each can elicit different behavioral responses, such as withdrawal (to avoid tissue injury) and scratching (to remove irritants), respectively. This leads to the fundamental question of whether there are DRG neurons whose primary function is to elicit itch, but not pain. Three important criteria should be met for neurons to be considered itch specific. First, these neurons should respond to itchy stimuli (pruritogens). Second, specific loss of these neurons should lead to a reduction in itch, but not pain. Third, and most importantly, specific activation of these neurons should evoke itch, but not pain.
There is ample evidence for different types of primary cutaneous neurons that respond to stimuli that elicit itch sensations in human and itch-associated behavior in animals. These neurons are subsets of nociceptive neurons that also respond to chemical, mechanical or heat stimuli that elicit pain in humans or pain behavior in animals and not itch or itch behavior. For example, in human nerve, there are mechanically insensitive cutaneous C fibers whose responses to histamine correspond to the itch produced 3 , but which also respond to noxious heat and/or one or more painful chemicals such as capsaicin 4 .
There are other C fibers in humans, monkeys and mice that respond to heat and mechanical noxious stimuli, but whose responses to cowhage spicules correspond to the histamine-independent itch this stimulus produces [5] [6] [7] [8] [9] . Given that neurons that are responsive to pruritic chemical agents such as histamine are also activated by painful stimuli, there is uncertainty as to whether their function is specific to the mediation of itch. The major hurdle to further investigation is the lack of specific molecular markers for labeling these neurons and molecular methods of manipulating their contribution to itch.
Previously, we found that certain Mrgpr genes, encoding a large family of G protein-coupled receptors, specifically expressed in subsets of small-diameter DRG neurons, function as receptors for certain pruritogens and mediate itch-associated behavior (scratching) accordingly. For example, MrgprA3 is a receptor for the anti-malarial drug chloroquine and mediates its direct activation of DRG neurons and chloroquine-induced site-directed scratching 10, 11 . Bovine adrenal medulla peptide [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] and SLIGRL-NH 2 , each capable of eliciting a histamine-independent itch, act through MrgprC11 (refs. 11-13) . Given that the expression of MrgprA3 and MrgprC11 largely overlaps in DRG neurons 14 , most chloroquine-sensitive neurons also respond to BAM8-22 and SLIGRL-NH 2 11,13 . As histamine can activate all chloroquine-sensitive neurons, MrgprA3 + neurons therefore respond to at least four different pruritogens 11 . Thus, MrgprA3 + neurons are good candidates as neurons specifically dedicated to eliciting itch and itch-associated behavior. To test this hypothesis, we generated a transgenic mouse line in which Cre recombinase is specifically expressed in MrgprA3 + neurons. Using this genetic tool, we found that MrgprA3 expression defines a specific population of itch-mediating neurons and determined the molecular identity and cellular properties of these neurons.
RESULTS

Generation of Mrgpra3 GFP-Cre transgenic mouse line
To investigate the function of MrgprA3 + neurons, we generated a bacterial artificial chromosome (BAC) transgenic mouse line in which the GFP-Cre fusion protein was expressed under the control of the Mrgpra3 promoter ( Fig. 1) . The Mrgpra3 GFP-Cre transgenic line was fertile and showed no obvious phenotypic or behavioral abnormalities. We crossed Mrgpra3 GFP-Cre mice with Cre-dependent ROSA26 tdTomato reporter mice 15 in which Cre-active neurons are marked by the expression of tdTomato ( Fig. 1a) . Because of the strong fluorescence of tdTomato, these neurons can be visualized directly by epifluorescence without immunohistochemical staining ( Fig. 1c,e,h) . We used antibodies to GFP to stain adult DRG sections from Mrgpra3 GFP-Cre ; ROSA26 tdTomato mice. All GFP and tdTomato signals were colocalized in a subset of small-diameter sensory neurons (312 double-labeled neurons from 3 mice; Fig. 1b-d) .
To characterize Cre activity in the MrgprA3 + neurons, we performed Mrgpra3 in situ hybridization on DRG sections from Mrgpra3 GFP-Cre ; ROSA26 tdTomato mice. We collected tdTomato fluorescent images and bright field images of each DRG section before the in situ procedure and matched them to the same DRG section afterward ( Fig. 1e,f) . Of the tdTomato + neurons examined (389 neurons from 3 mice), 97.2 ± 0.6% exhibited the MrgprA3 in situ signal and 95.5 ± 0.5% of these MrgprA3 + in situ neurons (396 MrgprA3 + neurons from 3 mice) were also tdTomato + , suggesting that the expression of GFP-Cre is tightly controlled by the endogenous Mrgpra3 promoter.
Previously, we found that chloroquine activates MrgprA3 and induces calcium influx and action potentials in dissociated MrgprA3 + neurons 11 . To further characterize the Mrgpra3 GFP-Cre transgenic line, we used Ca 2+ imaging to examine the responses of dissociated GFP-Cre-labeled DRG neurons to chloroquine. Of the 112 tdTomato + neurons obtained from three Mrgpra3 GFP-Cre ; ROSA26 tdTomato mice, 90.8 ± 4.6% showed robust increases in intracellular Ca 2+ following chloroquine application ( Fig. 1g-k) . In whole-cell patch-clamp recording, 10 of 11 GFP-Cre + neurons from Mrgpra3 GFP-Cre transgenic mice displayed a train of action potentials following chloroquine treatment.
In contrast, GFP-Creneurons failed to generate action potentials after a similar treatment ( Fig. 1l) . To examine the expression pattern of GFP-Cre, we performed reverse transcription PCR (RT-PCR) with intron-spanning primers on various adult mouse tissues. Among the tissues tested, GFP-Cre was found only in the DRG and trigeminal ganglia, which is consistent with the expression pattern of MrgprA3 (ref. 11; Fig. 1m ). Taken together, these data indicate that we successfully generated a transgenic line in which GFP-Cre is specifically expressed in MrgprA3 + neurons and that acts as a powerful tool to examine the function of MrgprA3 + neurons.
MrgprA3 + neurons represent a unique IB4 + CGRP + population Previously, we used in situ hybridization to examine the coexpression of MrgprA3 with different molecular markers and found that MrgprA3 + neurons are a subset of small-diameter neurons with nociceptive characteristics 16 . Using the Mrgpra3 GFP-Cre transgenic line, we examined the cellular features of MrgprA3 neurons with higher sensitivity. We collected lumbar level 4-6 (L4-L6) DRG sections from Mrgpra3 GFP-Cre ; ROSA26 tdTomato mice and stained them with antibodies to a number of neuronal markers ( Fig. 2a-r) . Of the 174 tdTomato + neurons that we examined, 79.1% expressed the nonpeptidergic nociceptive marker IB4 ( Fig. 2a-c) . For another 130 tdTomato + neurons, 84.7% expressed P2X3 and 97.6% expressed c-RET ( Fig. 2d-i) . None of the MrgprA3 + neurons expressed the peptidergic marker substance P (156 tdTomato + neurons; Fig. 2m -o) or the myelinated neuronal marker neurofilament 200 (NF200, 200 tdTomato + neurons; Fig. 2p-r) . In addition, of 184 tdTomato + neurons, 84.2% of MrgprA3 + neurons coexpressed another peptidergic marker, calcitonin generelated peptide (CGRP). CGRP expression appeared to be lower in MrgprA3 + neurons than in many other neurons that expressed the peptide ( Fig. 2j-l) . When DRG sections were stained with antibodies npg a r t I C l e S to CGRP and IB4, 63.1% of the MrgprA3 + neurons expressed both CGRP and IB4 (106 tdTomato + neurons; Supplementary  Fig. 1a-d) . Thus, MrgprA3 + neurons represent a unique population of DRG neurons that are labeled by both the nonpeptidergic marker IB4 and the peptidergic marker CGRP.
In addition, we performed double-labeling experiments using antibodies to TRPV1 and tdTomato in DRG and found that 19% of TRPV1 + DRG neurons coexpressed MrgprA3, whereas 88.3% of MrgprA3 + neurons coexpressed TRPV1 ( Supplementary Fig. 1e-g) . Furthermore, 93.3% of MrgprA3 + neurons expressed MrgprC11 ( Supplementary Fig. 1h-k) .
MrgprA3 + neurons exclusively innervate the epidermis
To determine the peripheral targets of MrgprA3 + neurons, we examined an extensive array of tissues from Mrgpra3 GFP-Cre ; ROSA26 tdTomato mice by visualizing the tdTomato fluorescence of MrgprA3 + nerve fiber terminals in the skin and other tissues. We found that MrgprA3 + neurons exclusively innervated the epidermis of the skin (Fig. 2s-v and Supplementary Table 1 ). MrgprA3 + fibers were occasionally seen wrapping around hair follicles. There was also innervation of glabrous skin, although to a lesser extent than in hairy skin. In contrast, MrgprA3 + nerve fibers were completely absent from all other tissues examined in the rest of the body, including lung, heart, stomach, muscle and cornea (Supplementary Table 1 
).
A well-known neuronal population that exclusively innervates the epidermis is the MrgprD-expressing DRG neurons 17 . To examine whether MrgprD + and MrgprA3 + fibers innervate distinct regions of the epidermis, we crossed Mrgpra3 GFP-Cre ; ROSA26 tdTomato mice with MrgprD-GFP knock-in mice in which MrgprD + neurons are labeled with GFP (Mrgprd GFP/+ ) 17 . Sections from the hairy skin of Mrgpra3 GFP-Cre ; ROSA26 tdTomato ; Mrgprd GFP/+ mice were collected and stained with antibody to GFP. As Cre is a nuclear protein, the fusion protein of GFP-Cre is present in the nucleus and not in axons. tdTomato is a cytoplasmic protein and therefore fills the entire axon of the neuron. Thus, MrgprA3 + fibers in Mrgpra3 GFP-Cre ; Rosa26 tdTomato mice were red, rather than yellow (green + red). MrgprA3 + fibers (red) could be easily distinguished from MrgprD + fibers, which were green. We found that MrgprA3 + and MrgprD + fibers represent two distinct nerve fiber populations ( Fig. 2t-v) , which is consistent with previous in situ hybridization results showing that Mrgprd and Mrgpra3 are expressed in non-overlapping DRG neurons 18 . Both MrgprA3 + and MrgprD + free nerve endings penetrated the epidermis and terminated in the same layer of the superficial skin surface, the stratum granulosum ( Fig. 2t-v) .
The central projections of MrgprA3 + fibers co-terminated with IB4 + fibers in spinal lamina II middle (Supplementary Fig. 1l ) 17 . This portion of lamina II is ventral to the CGRP + lamina and dorsal to the PKCγ lamina ( Supplementary Fig. 1m-o) . Although we found that MrgprA3 + neurons expressed CGRP in cell bodies in the DRG ( Fig. 2j-l) , only minimal overlap between the MrgprA3 + central projections and the terminals of other CGRP + neurons was observed ( Supplementary  Fig. 1m ). This could be explained by the fact that MrgprA3 expression is restricted to cell bodies with low CGRP expression.
MrgprA3 + fibers connect with GRPR + neurons in spinal cord
There is evidence that spinal dorsal horn neurons expressing gastrinreleasing peptide receptor (GRPR) mediate chemically evoked scratching behavior in mice 19, 20 . The ablation of GRPR + neurons abolishes scratching responses to multiple pruritic stimuli without altering behaviors in standard tests of pain behavior, suggesting that GRPR + neurons are dedicated pruriceptive neurons in the CNS 20 . We asked whether MrgprA3 + central fibers form direct connections with GRPR + neurons in the spinal cord ( Fig. 3) . We triple stained spinal cord sections for MrgprA3 + fibers (tdTomato), GRPR + neurons and the synaptic contacts between them (via the presynaptic marker synapsin-1). We found that a majority (67%) of GRPR + neurons formed synapses with MrgprA3 + primary afferents in dorsal horn ( Fig. 3a-k) .
We then asked whether chloroquine injection could preferentially activate GRPR + neurons. Using c-Fos induction as the marker for chloroquine-responsive neurons in the spinal cord, we examined whether c-Fos colocalized with GRPR. Fos-GFP hemizygous transgenic mice in which the expression of a c-Fos-GFP fusion protein is controlled by the Fos promoter 21 were used for this experiment. We injected 10 µl of chloroquine into the dorsal calf of the right hindlimb of the Fos-GFP mice and, 90 min after the injection, collected the L3-L5 frozen spinal cord sections and stained them with antibodies to GFP and GRPR. Chloroquine injection induced robust c-Fos expression in the Fig. 3m,o,q,r) . In contrast, when we applied hot water (50 °C) onto the same region of the skin, only 18.7 ± 1.7% of the heat-evoked c-Fos + neurons coexpressed GRPR (three mice, 380 c-Fos + neurons; Fig. 3l ,n,p,r). Taken together, our results indicate that MrgprA3 + primary afferents form direct synaptic connections with GRPR + , specific pruriceptive neurons in the dorsal horn. The different patterns of c-Fos induction by chloroquine (itchy) and noxious heat (painful) provide additional support for our conclusion that MrgprA3 + neurons in DRG are itch-mediating neurons.
MrgprA3 + neurons are cutaneous C-polymodal nociceptors
We then studied MrgprA3 + neurons in a more physiologically relevant setting with an in vivo electrophysiological recording method that we recently developed ( Fig. 4) 22 . We first examined MrgprA3 + neurons by visualizing GFP-Cre fluorescence in the nuclei and then applying mechanical, heat and chemical stimuli to their cutaneous receptive fields ( Fig. 4a-c,f) . A total of 16 DRG neurons expressing MrgprA3 were identified. All of these MrgprA3 + neurons had cutaneous nociceptors with C fibers (conduction velocity range = 0.46-0.81 m s -1 ; Fig. 4c ) that responded to both mechanical and heat noxious stimuli ( Fig. 4d,e ; but not to cold, data not shown). They were therefore classified as C-mechanoheat (CMH) polymodal nociceptors.
The following chemicals were injected intradermally into the receptive field in random order: vehicle (saline), histamine, BAM8-22, chloroquine and capsaicin. At least 5 min elapsed between the termination of action potential discharges evoked by one injection and the application of the next. The neurons were silent (that is, not spontaneously active) before each chemical application, and the injection of vehicle (n = 9) never evoked any response (that is, no discharges beyond the insertion of the needle). All neurons tested responded to histamine (n = 9) and to capsaicin (n = 9). Action potentials were evoked by BAM8-22 in eight of ten neurons tested, and by chloroquine in seven of nine neurons (Fig. 4f ). Cowhage spicules (in groups of 3-5) inserted into the receptive field also evoked responses in all of the neurons that we tested (n = 4). In addition, MrgprA3 + neurons did not respond to β-alanine (50 mM, n = 9), an agonist for MrgprD, which is expressed in a non-overlapping DRG subpopulation 16, 23 .
Ablation of MrgprA3 + neurons does not alter pain behavior
One efficient and broadly applicable approach to investigate the function of specific cell populations in the context of the whole organism is to ablate the targeted cell population 24 adults is commonly used to avoid compensation during development and can be achieved by expressing human heparin-binding epidermal growth factor-like growth factor precursor (HB-EGF, also referred to as DTR), which is the receptor for the cytotoxic protein diphtheria toxin (DTX) 25, 26 . We selectively ablated MrgprA3 + neurons by crossing the Mrgpra3 GFP-Cre transgenic line with the Cre-dependent ROSA26 DTR line 27 , followed by DTX injection (Fig. 5) . All of the MrgprA3 + neurons were lost 3 weeks after DTX injection (6.8 ± 0.6% versus 0%; Fig. 5a-c,f) . In contrast, the percentage of TrkA + neurons was not changed (23.7 ± 3.6% versus 24.5 ± 1.8%; Fig. 5d-f) .
To confirm the specificity of the ablation, we examined several subpopulations of DRG neurons by staining for various molecular markers. The proportions of CGRP-, IB4-, substance P-and NF200-immunoreactive neurons were similar in DTX-treated Mrgpra3 GFP-Cre ; ROSA26 DTR mice and ROSA26 DTR littermates (Supplementary Fig. 2a-o) , suggesting that DTX treatment did not produce any general neurotoxic effects.
We tested the responses of Mrgpra3 GFP-Cre ; ROSA26 DTR mice to acute noxious heat, cold, mechanical and chemical stimulation after DTX administration. DTX-treated Mrgpra3 GFP-Cre ; ROSA26 DTR mice exhibited equivalent thermal sensitivities as DTX-treated ROSA26 DTR littermates in the Hargreaves, hot plate, cold plate and tail immersion tests (n ≥ 6 for each group, P > 0.5 for each test; Supplementary  Fig. 3a-d) . Thus, MrgprA3 + neurons are dispensable for normal pain behavior to heat and cold noxious stimuli. Both groups also showed similar mechanical sensitivity as measured by von Frey filament responses (Supplementary Fig. 3e ). Injection of capsaicin or formalin into the right hindpaw of the animals evoked comparable licking and flinching behaviors in the DTX-treated Mrgpra3 GFP-Cre ; ROSA26 DTR mice and ROSA26 DTR littermates (Supplementary Fig. 3f,g) . Taken together, these results indicate that MrgprA3 + neurons are not required for acute pain sensation. In addition, inflammatory hyperalgesia, induced by complete Freund's adjuvant injected into the paw, was not affected in DTX-treated Mrgpra3 GFP-Cre ; ROSA26 DTR mice compared with DTXtreated ROSA26 DTR littermates (Supplementary Fig. 3i,j) , suggesting that MrgprA3 + neurons are not required for inflammatory pain. Finally, MrgprA3 + neuron-ablated mice showed normal motor function as determined by the rotarod test (Supplementary Fig. 2p) . Thus, the genetic manipulations leading to the ablation of MrgprA3 + neurons had no effects on the neuronal systems mediating pain or motor function.
Ablation of MrgprA3 + neurons reduces itch behavior
We next evaluated whether itch-associated behaviors were affected by the ablation of MrgprA3 + neurons. Indeed, site-directed scratching in response to the subcutaneous injection of chloroquine into the nape of the neck was significantly reduced in DTX-treated Mrgpra3 GFP-Cre ; ROSA26 DTR mice compared with DTX-treated ROSA26 DTR littermates (P = 0.0005; Table 1 ). In addition, the ablation of MrgprA3 + neurons also abolished the site-directed scratching induced by BAM8-22 and SLIGRL-NH 2 , two pruritogens activating MrgprC11 ( Table 1 ). The total number of scratching bouts exhibited by DTX-treated Mrgpra3 GFP-Cre ; ROSA26 DTR mice after BAM8-22 or SLIGRL-NH 2 injected into the nape of the neck were comparable to that of the wild-type group injected with saline (SLIGRL, P = 0.78; BAM8-22, P = 0.20; Table 1 ). We also tested whether MrgprA3 + neurons are required for histamine-induced scratching. Subcutaneous injection of histamine into the nape of the neck induced strong scratching behavior in DTX-treated ROSA26 DTR mice, whereas DTX-treated Mrgpra3 GFP-Cre ; ROSA26 DTR mice exhibited a significant decrease in the total number of scratching bouts (P = 0.005; Table 1 ), indicating that MrgprA3 + neurons were important for normal histamine-induced scratching behavior. However, these neurons were not the only neurons that were responsive to this chemical, as evidenced by the residual behavior. We tested scratching behaviors evoked by another two pruritogens, alpha-methyl-serotonin (α-Me-5HT) and endothelin-1 (ET-1) 28 . Both α-Me-5HTand ET-1-induced scratching behaviors were significantly reduced in the DTX-treated Mrgpra3 GFP-Cre ; ROSA26 DTR mice (P = 0.024) compared with the DTX-treated ROSA26 DTR littermates (P = 0.047; Table 1 ).
We next examined the role of MrgprA3 + neurons in chronic itch conditions by using dry skin and allergic itch mouse models. Dry skin pruritus is a common symptom in patients with xerosis and atopic dermatitis, as well as systemic disorders, including cholestasis and chronic renal failure 29, 30 . Using a murine model for dry skin pruritus 31 npg a r t I C l e S we found that the spontaneous scratching response decreased significantly after ablation of MrgprA3 + neurons (P = 0.0006; Table 1 ).
Itch is always associated with allergic chronic disease, such as allergic conjunctivitis and allergic contact dermatitis [32] [33] [34] . However, little is known of the sensory neurons that mediate allergic itch. In a mouse model of ovalbumin-induced allergic itch 30 , we found that the ablation of MrgprA3 + neurons significantly inhibited scratching behaviors (P = 0.01; Table 1 ).
Previous reports have shown that mice exhibit distinct behaviors directed to cheek injection of pruritogens versus algogens 35 . Pruritogens elicit scratching with the hindpaw, whereas algogens evoke facial wiping with the forelimb. This model provides a reliable means of distinguishing pain and itch behaviors. Injection of chloroquine in the cheek evoked robust hindpaw scratching on the cheek in the DTX-treated ROSA26 DTR mice without any facial wiping. However, the scratching responses were completely abolished in the DTX-treated Mrgpra3 GFP-Cre ; ROSA26 DTR mice (chloroquine-injected ablated mice, 12.8 + 3.6 bouts; saline-injected wild-type mice, 6 ± 3.1 bouts; P = 0.16; Table 1 ). Hindpaw scratching induced by the administration of histamine in the cheek was also significantly reduced, although not eliminated after the ablation of MrgprA3 + neurons (P = 0.026; Table 1 ). In contrast, facial wiping by the forepaw induced by capsaicin injection was not altered (Supplementary Fig. 3h) , supporting the conclusion that MrgprA3 + neurons are specific for mediating itch behavior, but are not required for pain behavior. Recently, we found that intradermal injection of the amino acid β-alanine elicited itch in humans and site-directed scratching in mice 36 . Consistent with the finding that MrgprA3 and MrgprD define two separate subpopulations of DRG neurons 18 , cheek injection of β-alanine also induced a robust scratching response in DTX-treated Mrgpra3 GFP-Cre ; ROSA26 DTR mice ( Table 1 ). The total number of scratching bouts was comparable for the two groups, indicating that MrgprA3 + neurons are dispensable for β-alanine-induced itch behavior. In summary, the ablation of MrgprA3 + neurons attenuated itch behaviors not only in acute conditions induced by an array of pruritogens, but also in chronic itch conditions. MrgprA3 + neurons mediate only itch and not pain behavior Our findings do not preclude the possibility that MrgprA3 + neurons may also mediate pain and that their ablation has no substantial effect on pain behavior as a result of compensation from other painmediating neurons. One way to rule out this possibility is to selectively activate only MrgprA3 + neurons with a stimulus that normally elicits pain, but not itch, behavior. If both pain and itch behaviors occur, then the activation of these neurons mediates both types of behavior, whereas if itch behavior alone occurs, then the activation of these neurons is specifically linked to itch regardless of the type of stimulus that activates the neuron. Our approach was to exclusively express the algogen receptor TRPV1 in MrgprA3 + neurons. A previous study found that the Cre-dependent ROSA26-TRPV1 knock-in mouse line expresses TRPV1 in a specific neuronal population 37 . In these mice, capsaicin can evoke action potential firing in the targeted neurons and induce behavioral responses 37, 38 . We generated Trpv1 −/− ; Mrgpra3 GFP-Cre ; ROSA26 Trpv1 mice by crossing Mrgpra3 GFP-Cre mice with ROSA26 Trpv1 mice (to re-express TRPV1 in MrgprA3 + neurons) in the TRPV1 knockout background (to eliminate TRPV1 from all cells) ( Fig. 6) . We first tested specific functional expression of the Trpv1 transgene in MrgprA3 + neurons by calcium imaging using DRG neurons in acute culture. For cultured neurons sampled from wild-type mice (n = 396 neurons), Trpv1 −/− mice (n = 305) and Trpv1 −/− ; Mrgpra3 GFP-Cre ; ROSA26 Trpv1 mice (n = 346), the incidences of responses to chloroquine were virtually the same (wild type, 5.9 ± 1.2%; Trpv1 −/− , 5.75 ± 0.4%; Trpv1 −/− ; Mrgpra3 GFP-Cre ; ROSA26 Trpv1 , 8 ± 1.3%; n = 3 mice per genotype; Fig. 6a-c,e,f,h) . We next analyzed the responsiveness of cultured DRG neurons from the three genotypes of mice to capsaicin. Of the DRG neurons from wild-type mice, 37.2% responded to capsaicin. Neurons from Trpv1 −/− did not respond to capsaicin. However, 6.6% of neurons from Trpv1 −/− ; Mrgpra3 GFP-Cre ; ROSA26 Trpv1 mice responded to capsaicin (Fig. 6d,g,h) . Notably, every capsaicin-responding neurons from Trpv1 −/− ; Mrgpra3 GFP-Cre ; ROSA26 Trpv1 mice responded to chloroquine ( Fig. 6e-g) , indicating that TRPV1 is exclusively expressed in MrgprA3 + neurons.
We then used the cheek injection model 35 to examine whether pain or itch behaviors or both are triggered by an intradermal injection of capsaicin when TRPV1 is exclusively expressed in MrgprA3 + neurons (Fig. 7) . In response to capsaicin injected into the cheek, wild-type mice exhibited robust site-directed wiping (using the forepaw) and little if any scratching (with the hind paw), which is indicative of pain behavior. Trpv1 −/− mice exhibited neither wiping nor scratching in response to cheek injection of capsaicin. In contrast, Trpv1 −/− ; Mrgpra3 GFP-Cre ; npg a r t I C l e S ROSA26 Trpv1 mice injected with capsaicin exhibited robust sitedirected scratching behaviors with little or no wiping (Fig. 7a,b) , indicating that the selective activation of MrgprA3 + neurons by capsaicin elicited itch, but little or no pain. As a control, cheek injection of mustard oil evoked similar numbers of wiping in all three groups of mice with little or no scratching, suggesting that pain sensation mediated by other TRPs (for example, TRPA1) functions normally in Trpv1 −/− ; Mrgpra3 GFP-Cre ; ROSA26 Trpv1 mice (Fig. 7c,d) .
In addition, these mice showed similar mechanical sensitivity as measured by von Frey filament responses (Fig. 7g) . TRPV1 is essential for detecting noxious heat. As previously shown, Trpv1 −/− mice exhibited significantly longer tail flick latency in response to 50 °C in the tail immersion test than wild-type mice 39 (P = 2.3 × 10 −7 ; Fig. 7e) . A similar impaired response was obtained in the hot plate assay 39 (Fig. 7f) . Notably, Trpv1 −/− ; Mrgpra3 GFP-Cre ; ROSA26 Trpv1 mice have similar latencies in both assays as those in Trpv1 −/− mice, suggesting that re-introducing TRPV1 in MrgprA3 + neurons in Trpv1 −/− mice did not rescue any deficit in sensing noxious heat (Fig. 7e,f) .
DISCUSSION
A cellular basis for itch being felt only in the skin Previously, we found that MrgprA3 functions as a receptor for the pruritogen chloroquine. Because of its specific expression in DRG, the Mrgpra3 promoter provides the first means of answering some fundamental questions. Do itch-specific neurons exist? If so, what is the molecular identity of these neurons and what are the cellular and functional properties of these neurons?
One aspect of itch sensation is that itch arises from the skin, but not from deeper tissues, such as muscle, bone and visceral organs, from which pain can be felt. Our results provide a cellular basis of this phenomenon: MrgprA3 + axons exclusively innervate the skin. It has been suggested that itch-mediating nerve fibers terminate in the superficial skin layer. The traditional algogen, capsaicin, generates pain when delivered intradermally, but can evoke an initial sensation of itch when applied topically or by means of a cowhage spicule to the skin [40] [41] [42] . One possible explanation is that itch-mediating nerve fibers innervate more superficially and can be chemically activated more selectively by spicule than other fibers that are readily activated by intradermal injection. Indeed, MrgprA3 + axons penetrate the epidermis and terminate in the stratum granulosum layer.
MrgprA3 + neurons mediate multiple types of itch
We found that MrgprA3 + neurons responded to multiple chemical pruritogens (Fig. 3) . The ablation of MrgprA3 + neurons reduced itch behavior in response to all of the pruritic chemicals that were tested except β-alanine, including those that are known to directly activate Mrgpr proteins (chloroquine, BAM 8-22 and SLIGRL) 11, 13 and those that activate other receptors (histamine, ET-1 and α-Me-5HT) 1, 43, 44 . In addition, the responsiveness of MrgprA3 + neurons to algesic stimuli, namely capsaicin, heat and mechanical stimuli, provide a mechanism by which noxious stimuli, such as the punctuate application of such stimuli, might under certain conditions elicit itch. Of clinical relevance is our observation that the spontaneous scratching from dry skin or from allergic responses was substantially attenuated in MrgprA3-ablated mice. Together, these data imply that MrgprA3 + neurons express a broad array of receptors for pruritic stimuli and are involved in mediating both acute and chronic itch.
The insensitivity of MrgprA3 + neurons to β-alanine and the normal scratching responses to β-alanine in MrgprA3-ablated mice also support the existence of multiple types of itch-mediating neurons. In addition, the residual scratching induced by certain pruritogens, especially histamine, ET-1 and α-Me-5HT, in MrgprA3-ablated mice indicate that other types of DRG neurons are also involved in mediating itch. For example, at least two types of neurons must mediate histamine-evoked itch behavior, namely MrgprA3 + neuron and another, as yet unknown type that must contribute to the histamineevoked scratching in mice that remains after MrgprA3 + neurons are ablated. Perhaps the latter neurons have properties similar to a r t I C l e S the histamine-responsive, mechanically insensitive neurons with C fibers that have been recorded in humans 3, 4 .
TRPV1 + neurons belong to parallel pain and itch pathways
Our data indicate that MrgprA3 + neurons are also TRPV1 + and sensitive to capsaicin and noxious heat. Specific ablation of this subpopulation of TRPV1 + neurons did not affect the pain behavior induced by noxious thermal, mechanical and chemical stimuli. Conversely, capsaicin injection in Trpv1 −/− ; Mrgpra3 GFP-Cre ; ROSA26 Trpv1 mice induced scratching, but not wiping, suggesting that the selective activation of the TRPV1 + subpopulation expressing MrgprA3 primarily evokes itch, but not pain. In addition, the response latencies to noxious heat of Trpv1 −/− ; Mrgpra3 GFP-Cre ; ROSA26 Trpv1 mice are similar to those of Trpv1 −/− mice, suggesting that, although MrgprA3 + neurons are sensitive to noxious heat, the activation of these neurons by noxious heat did not elicit pain behavior. The specific itch behavior that we obtained by selectively activating only the MrgprA3 + neurons provide direct support for the applicability of Muller's 1826 doctrine of specific nerve energies to a submodality of cutaneous sensations, namely the sensation of itch 45 . That is, the quality of sensation evoked by a stimulus depends on the specific neuronal pathway that is activated, regardless of the nature of the stimulus. In this case, if only MrgprA3 + neurons are activated by a stimulus, the sensation should be itch even if the stimulus is noxious mechanical, heat or chemical. However, we cannot rule out the possibility that weaker nociceptive sensations that humans typically report as accompanying itch may be present in mice, but of insufficient magnitude to elicit overt pain behavior. Our findings suggest that nociceptive, capsaicin-sensitive DRG neurons (that express TRPV1) consist of two types: one mediating itch and the other mediating pain. But if this is so, why does the activation of the entire population of TRPV1 + neurons by capsaicin (that is, in wild-type mice) only evoke pain and not itch behavior, even though MrgprA3 + neurons are also activated? One explanation is that the brain decodes activity in the pruriceptive neurons as itch only when there is minimal activity in the nociceptive neurons that do not mediate itch 46 . Another possibility is that there are central inhibitory mechanisms activated by the pain-mediating neurons that act to block transmission in an itch-mediating pathway [47] [48] [49] [50] . Indeed, in the VGLUT2 conditional knockout mice, in which nociceptors are silenced by disrupting glutamatergic transmission, capsaicin evokes itch rather than pain behavior 49 . It would be important to determine which VGLUT is expressed in MrgprA3 + neurons and whether glutamate is essential for itch signaling transmission in these neurons. To study neurons mediating pain from capsaicin injection, we need to develop new genetic tools to specifically manipulate TRPV1 + in these neurons (versus itch mediating, for example, MrgprA3 + neurons). Currently available DRG-specific Cre lines drive gene expression not only in small-diameter neurons with C fibers, but also in most other types of DRG neurons, including those with large-diameter Aβ fibers, which would make interpretation of behavioral data difficult.
The search for pruriceptive neurons mediating itch began nearly a century ago. Here, we have defined and characterized a specific subpopulation of itch-mediating neurons, which should open new avenues for advancing itch research as well as foster the development of itch therapies that target this population.
METhODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary information is available in the online version of the paper.
